SiSaf is a specialty biopharmaceutical company with a next-gen drug delivery technology that can solve even the most extreme drug challenges Vickers Venture Partners, a global VC fund co-founded by Baidu’s early investor Dr Finian Tan, has co-invested in the US$3.5 million Series A funding round of SiSaf, a nanotechnology drug delivery company based in...
The post Vickers Venture Partners co-invests in drug delivery tech company SiSaf’s US$3.5M Series A appeared first on e27.
More...
The post Vickers Venture Partners co-invests in drug delivery tech company SiSaf’s US$3.5M Series A appeared first on e27.
More...
via VRForums | Singapore Technology Lifestyle Forums - News around the web! http://ift.tt/2de4UJ0
No comments:
Post a Comment